↓ Skip to main content

Long Circulating Liposomes: Old Drugs, New Therapeutics

Overview of attention for book
Cover of 'Long Circulating Liposomes: Old Drugs, New Therapeutics'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 Long Circulating Liposome Therapeutics: From Concept to Clinical Reality
  3. Altmetric Badge
    Chapter 2 Oncologic Agents in Sterically Stabilized Liposomes: Basic Considerations
  4. Altmetric Badge
    Chapter 3 Liposomal Vincristine: The Central Role of Drug Retention in Defining Therapeutically Optimized Anticancer Formulations
  5. Altmetric Badge
    Chapter 4 Long Circulating Liposome-Encapsulated Tumor Necrosis Factor in the Treatment of Solid Tumors
  6. Altmetric Badge
    Chapter 5 Therapy of Human Carcinoma Xenografts with Doxorubicin Encapsulated in Sterically Stabilized Liposomes (DOXIL®): Efficacy and Safety Studies
  7. Altmetric Badge
    Chapter 6 Design and Development of Long Circulating Liposomal Daunorubicin for In Vivo Targeting of Solid Tumors: DaunoXome®
  8. Altmetric Badge
    Chapter 7 Enhancement of Doxorubicin by Encapsulation in Long Circulating Thermosensitive Liposomes Combined with Local Hyperthermia
  9. Altmetric Badge
    Chapter 8 Liposomal Localization and Chemotherapy for AIDS-Related Kaposi’s Sarcoma
  10. Altmetric Badge
    Chapter 9 Pegylated-Liposomal Doxorubicin (Doxil®) in the Treatment of AIDS-Related Kaposi’s Sarcoma
  11. Altmetric Badge
    Chapter 10 DaunoXome® (Liposomal Daunorubicin) for First-Line Treatment of Advanced, HIV-Related Kaposi’s Sarcoma
  12. Altmetric Badge
    Chapter 11 Initial Clinical Evaluation of Pegylated-Liposomal Doxorubicin in Solid Tumors
  13. Altmetric Badge
    Chapter 12 Antibacterial Therapy with Sterically Stabilized Liposome Formulations
  14. Altmetric Badge
    Chapter 13 AmBisome®: Long Circulating Liposomal Formulation of Amphotericin B
  15. Altmetric Badge
    Chapter 14 Steric Stabilization of Liposomes Containing Amphotericin B: A Future Direction in Antifungal Therapy?
  16. Altmetric Badge
    Chapter 15 Clinical and Preclinical Studies with Low-Clearance Liposomal Amikacin (MiKasome®)
  17. Altmetric Badge
    Chapter 16 Sterically Stabilized Liposomes to Image Infection and Inflammation
  18. Altmetric Badge
    Chapter 17 Long Circulating Liposomes for Diagnostic Imaging
  19. Altmetric Badge
    Chapter 18 Tumor Imaging with Long Circulating Liposomes
  20. Altmetric Badge
    Chapter 19 Antibody-Mediated Targeting of PEG-Coated Liposomes
  21. Altmetric Badge
    Chapter 20 Small Molecule Ligands for Targeting Long Circulating Liposomes
Overall attention for this book and its chapters
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
54 Dimensions

Readers on

mendeley
20 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Long Circulating Liposomes: Old Drugs, New Therapeutics
Published by
Springer Berlin Heidelberg, January 1998
DOI 10.1007/978-3-662-22115-0
ISBNs
978-3-66-222117-4, 978-3-66-222115-0
Editors

Woodle, Martin C., Storm, Gerrit

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 20 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
India 1 5%
Colombia 1 5%
Unknown 18 90%

Demographic breakdown

Readers by professional status Count As %
Student > Master 5 25%
Student > Ph. D. Student 5 25%
Student > Doctoral Student 1 5%
Researcher 1 5%
Professor > Associate Professor 1 5%
Other 0 0%
Unknown 7 35%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 2 10%
Materials Science 2 10%
Chemistry 2 10%
Chemical Engineering 1 5%
Agricultural and Biological Sciences 1 5%
Other 3 15%
Unknown 9 45%